PARTELLI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 7.941
AS - Asia 7.299
NA - Nord America 5.811
SA - Sud America 1.514
AF - Africa 145
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.732
Nazione #
US - Stati Uniti d'America 5.501
RU - Federazione Russa 4.583
SG - Singapore 2.551
CN - Cina 2.243
BR - Brasile 1.241
HK - Hong Kong 901
SE - Svezia 790
IT - Italia 789
VN - Vietnam 663
DE - Germania 351
FR - Francia 332
BD - Bangladesh 322
RO - Romania 267
GB - Regno Unito 246
IN - India 186
FI - Finlandia 168
CA - Canada 162
AR - Argentina 116
MX - Messico 88
ES - Italia 73
PL - Polonia 71
JP - Giappone 68
AT - Austria 60
ZA - Sudafrica 56
IE - Irlanda 54
ID - Indonesia 53
NL - Olanda 53
TR - Turchia 47
EC - Ecuador 41
IQ - Iraq 38
CO - Colombia 33
PK - Pakistan 30
NP - Nepal 25
PH - Filippine 22
LT - Lituania 21
PY - Paraguay 21
UA - Ucraina 20
UZ - Uzbekistan 19
MA - Marocco 18
MY - Malesia 18
VE - Venezuela 18
CL - Cile 17
EG - Egitto 15
AU - Australia 14
DZ - Algeria 14
CR - Costa Rica 12
KE - Kenya 12
SA - Arabia Saudita 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
PE - Perù 11
BE - Belgio 10
JM - Giamaica 10
IL - Israele 9
IR - Iran 9
JO - Giordania 9
KZ - Kazakistan 9
UY - Uruguay 9
BH - Bahrain 8
CH - Svizzera 8
MD - Moldavia 8
PT - Portogallo 7
RS - Serbia 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
HN - Honduras 6
NI - Nicaragua 6
TW - Taiwan 6
GR - Grecia 5
PS - Palestinian Territory 5
TH - Thailandia 5
GE - Georgia 4
GT - Guatemala 4
KR - Corea 4
OM - Oman 4
PA - Panama 4
AO - Angola 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
LB - Libano 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AL - Albania 2
CY - Cipro 2
DK - Danimarca 2
EU - Europa 2
HU - Ungheria 2
KG - Kirghizistan 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SC - Seychelles 2
SN - Senegal 2
TG - Togo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AW - Aruba 1
Totale 22.712
Città #
Singapore 1.224
Moscow 955
Dallas 929
Ashburn 895
Hong Kong 886
San Jose 682
Shanghai 388
Beijing 328
Hefei 305
New York 303
Lauterbourg 252
Milan 236
Ho Chi Minh City 222
Los Angeles 207
Lawrence 197
Princeton 194
Hanoi 140
São Paulo 136
Boardman 107
Santa Clara 101
Munich 100
Helsinki 89
Orem 88
London 84
Nuremberg 78
Montreal 60
Chennai 59
Rome 55
Dublin 54
Warsaw 54
Tokyo 53
Rio de Janeiro 51
Turku 49
Denver 48
Frankfurt am Main 45
Poplar 44
Brooklyn 43
Atlanta 42
The Dalles 41
Chicago 40
Guangzhou 37
Manchester 37
Johannesburg 35
Stockholm 35
Council Bluffs 34
Mexico City 34
Phoenix 34
Toronto 34
Boston 31
Washington 31
Columbus 29
Belo Horizonte 27
Buffalo 27
Lappeenranta 27
Pune 27
Vienna 27
Da Nang 26
Haiphong 26
San Francisco 25
Brasília 23
Houston 23
Mumbai 23
Seattle 23
Shenzhen 22
Ankara 20
Cesano Boscone 20
Biên Hòa 19
Amsterdam 18
Dhaka 17
Tashkent 17
Tianjin 17
Campinas 16
Falkenstein 16
Thái Bình 16
Naples 15
Charlotte 14
New Delhi 14
Baghdad 13
Cape Town 13
Hải Dương 13
Ottawa 13
Porto Alegre 13
Ribeirão Preto 13
Turin 13
Asunción 12
Barnet 12
Bắc Ninh 12
Changsha 12
Madrid 12
Quito 12
Dalian 11
Guayaquil 11
Paris 11
Querétaro 11
Romagnano Sesia 11
San José 11
Assago 10
Guarulhos 10
Hangzhou 10
Joinville 10
Totale 11.049
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 357
Impact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis 210
Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence Risk 193
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study 192
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 179
Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma 176
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 175
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 169
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 160
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 160
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma 154
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 148
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 142
The impact of postoperative complications on recovery of Health-Related Quality of Life and Functional Capacity after pancreatectomy: findings from a prospective observational study 141
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 136
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 135
Effect of preoperative biliary stent on postoperative complications after pancreaticoduodenectomy for cancer: Neoadjuvant versus upfront treatment 132
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 129
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 128
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 125
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 123
The impact of preoperative anemia on pancreatic resection outcomes 122
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 118
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 118
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 117
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 116
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 116
Advantages of laparoscopic distal pancreatectomy: Systematic review and meta-analysis of randomized and matched studies 115
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis 115
Correction to: Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 (Updates in Surgery, (2023), 75, 6, (1439-1456), 10.1007/s13304-023-01592-7) 114
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 114
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors 114
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases 113
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition" 113
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 112
Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein 111
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 110
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 110
Correction to: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey (Updates in Surgery, (2024), 76, 3, (923-932), 10.1007/s13304-024-01836-0) 110
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness 108
Before sentinel bleeding: early prediction of postpancreatectomy hemorrhage (PPH) with a CT-based scoring system 108
Development of a predictive model for unplanned intensive care unit admission after pancreatic resection within an enhanced recovery pathway 106
Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 106
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 106
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 106
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 106
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy after Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients 106
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy 106
Recovery of health-related quality of life after laparoscopic versus open distal pancreatectomy 105
Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS) 105
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 104
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 104
The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 103
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 103
ASO Visual Abstract: Surgery for IPMN of the Pancreas-Preoperative Factors Tipping the Scale of Decision-Making 102
A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors 102
Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer 102
Impact of care pathway adherence on recovery following distal pancreatectomy within an enhanced recovery program 102
Clinical and Financial Validation of the International Study Group for Pancreatic Surgery (ISGPS) Definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study 102
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 101
Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours 101
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 101
A systematic review and meta-analysis of spleen-preserving distal pancreatectomy with preservation or ligation of the splenic artery and vein 100
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 99
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 99
Management of clinically relevant postoperative pancreatic fistula-related fluid collections after distal pancreatectomy 99
Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After Pancreatoduodenectomy 98
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 98
ASO Visual Abstract: Detecting Somatic Mutations for Well-Differentiated Pancreatic Neuroendocrine Tumors in Endoscopic Ultrasound-Guided Fine Needle Aspiration with Next-Generation Sequencing 98
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 97
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 97
Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial 96
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival 96
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life 96
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 95
Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy 95
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral center 95
Endoscopic and Surgical Management of Non-Metastatic Ampullary Neuroendocrine Neoplasia: A Multi-Institutional Pancreas2000/EPC Study 95
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 95
The impact of minimally invasive surgery on hospital readmissions, emergency department visits and functional recovery after distal pancreatectomy 95
Validation of the PROMIS-29 Questionnaire as a Measure of Recovery After Pancreatic Surgery 94
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 94
A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy 94
Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis 92
Non functional pancreatic neuroendocrine tumors 92
Single snapshot imaging of optical properties (SSOP) for perfusion assessment during gastric conduit creation for esophagectomy: An experimental study on pigs 92
Geographical Disparities and Patients’ Mobility: A Plea for Regionalization of Pancreatic Surgery in Italy 91
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 91
Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge 90
New Surgical Strategies 90
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma 89
ASO Author Reflections: Can We Evaluate Surgical Quality for Pancreatic Neuroendocrine Tumors? 88
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer 88
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 87
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 87
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 87
Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors: How to Deal with them in Clinical Practice? 86
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms 86
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 86
Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis 85
Totale 11.449
Categoria #
all - tutte 128.271
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.271


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 2 7 53 5 5 7 4 10 9 4 13
2022/20231.396 449 281 91 29 23 193 96 106 76 17 14 21
2023/20241.177 24 68 126 128 116 242 27 115 19 34 77 201
2024/20254.666 488 118 128 148 166 406 944 382 692 482 303 409
2025/202615.697 1.008 1.082 1.080 2.120 1.175 550 1.305 1.154 4.153 874 690 506
Totale 23.156